Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1606-1613
Published online before print June 12, 2008, doi: 10.1161/ATVBAHA.108.169235
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/9/1606    most recent
ATVBAHA.108.169235v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.-X.
Right arrow Articles by Stinnett, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.-X.
Right arrow Articles by Stinnett, A.
Related Collections
Right arrow Angiogenesis
Right arrow Type 2 diabetes
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1606.)
© 2008 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice

Jian-Xiong Chen; Amanda Stinnett

From the Department of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, Nashville, Tenn.

Correspondence to Jian-Xiong Chen, MD, Department of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, MRB IV-1125, Nashville, TN 37232-2650. E-mail Jian-xiong.chen{at}vanderbilt.edu

Objective— Microvascular insufficiency represents a major cause of end-organ failure among diabetics. The current studies were undertaken to determine whether dysregulation of the angiopoietins/Tie-2 system would result in an impairment of smooth muscle cell (SMC) recruitment and vascular maturation, which contributes to impaired angiogenesis in diabetes.

Methods and Results— Tie-2 expression was significantly attenuated, whereas angiopoietin-2 (Ang-2) was increased in db/db mice subjected to myocardial ischemia. Our morphological analysis showed that the number of SMC coverage area per neovessel was significantly reduced in db/db mice. This was accompanied by a significant reduction of myocardial capillary density and arteriole formation. Interestingly, Angiopoietin-1(Ang-1)–induced SMC recruitment and vessel outgrowth were severely impaired in db/db mice. Our in vitro studies further demonstrated that exposure of mouse heart endothelial cells to high glucose resulted in a significant upregulation of Ang-2 and a downregulation of Tie-2 expression. These alterations led to a significant impairment of Ang-1–induced Akt and eNOS phosphorylation, along with a remarkable impairment of Ang-1–induced endothelial cell migration and endothelial cell spheroid sprouting. Ang-1 gene transfer restored Tie-2 expression and rescued these abnormalities in diabetes.

Conclusions— Our findings underscore the important role of Ang-1–Tie-2 signaling in the diabetes-induced impairment of vascular maturation and angiogenesis.


Key Words: hyperglycemia • angiopoietins/Tie-2 • myocardial ischemia • angiogenesis • type II diabetes




This article has been cited by other articles:


Home page
DiabetesHome page
J.-X. Chen and A. Stinnett
Ang-1 Gene Therapy Inhibits Hypoxia-Inducible Factor-1{alpha} (HIF-1{alpha})-Prolyl-4-Hydroxylase-2, Stabilizes HIF-1{alpha} Expression, and Normalizes Immature Vasculature in db/db Mice
Diabetes, December 1, 2008; 57(12): 3335 - 3343.
[Abstract] [Full Text] [PDF]